Childhood Vasculitis Improved on Tocilizumab but Arteries Remain Damaged
A 12-year-old girl with refractory Takayasu arteritis had inflammation resolve after tocilizumab while established arterial stenoses, pulse deficits and blood-pressure ...
A 12-year-old girl with refractory Takayasu arteritis had inflammation resolve after tocilizumab while established arterial stenoses, pulse deficits and blood-pressure ...
A case report shows tocilizumab-induced hypofibrinogenemia recurred in a rheumatoid arthritis patient even after the drug dose was substantially reduced.
A systematic review of 138 pediatric cases finds influenza and SARS-CoV-2 account for nearly 90 percent of acute necrotizing encephalopathy ...
A new narrative review maps how methotrexate, biologics, and JAK inhibitors are transforming the management of pediatric morphea, a rare ...
A retrospective review of 35 published cases shows that nivolumab can trigger cytokine release syndrome weeks to months into treatment, ...
A comprehensive new review maps how clinicians are taming cytokine release syndrome, the most dangerous side effect of CAR T-cell ...
A case report details how HBsAg-targeted TCR-engineered T cells produced a manageable grade 3 cytokine release syndrome and a transient ...
A new review examines the 2026 Andes virus outbreak on the cruise ship MV Hondius, detailing the virus's unique human-to-human ...
A retrospective cohort study in China finds that the interleukin-6 blocker tocilizumab reduced seizures and improved disability scores in most ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine